Day: December 27, 2023

SAN SALVADOR, El Salvador, Dec. 27, 2023 (GLOBE NEWSWIRE) — Eco Bright Future, Inc. (“EBFI” or the “Company”) (OTC: EBFI) announces it has entered a Letter-of-Intent (“LOI”) with United Heritage, Sociedad Anonima De Capital Variable (“UNITED”), dated 20 December 2023. The LOI lays out the initial proposed terms and conditions pursuant to which the Company and UNITED will affect a business transaction that will result in a merger of the Company and the shareholders of UNITED (the “Proposed Transaction”). The entity resulting from the Proposed Transaction (the “Resulting Issuer”) will continue to carry on the business of UNITED as an artificial intelligence and blockchain technology company that utilizes real world tokenization (RWA) to create a virtual investment...

Atlanta, Dec. 27, 2023 (GLOBE NEWSWIRE) — Gray Television, Inc. (“Gray) (NYSE: GTN) today announced that it has reached an agreement in principle with the NBC Network that extends and renews all of Gray’s NBC network affiliations, which otherwise would have expired at year-end 2023.  Gray owns and operates NBC affiliated television stations serving 56 markets.  In the current 2023-24 television season, NBC is the #1 network and ranks first in all key demos, as well as first in primetime, morning/afternoon news, late night, primetime sports, scripted and alternative program categories. Gray Television, Inc. is a multimedia company headquartered in Atlanta, Georgia. Gray is the nation’s largest owner of top-rated local television stations and digital assets in the United States. Its television stations serve 113 television markets...

BBS-Bioactive Bone Substitutes Plc, Company Announcement, 27 December 2023 at 05.45 PM (EET) Merja Haikola appointed as Accountable Director (QP) of BBS-Bioactive Bone Substitutes Plc BBS-Bioactive Bone Substitutes Plc has appointed Merja Haikola (MS Chem.) as Accountable director (QP) as of 23.12.2023. The current Quality Director Soile Hakala will leave the Company’s service. Haikola has broad experience from similar positions in several companies in the pharmaceutical industry, including previous experience at BBS. ”I am pleased that Merja is joining the team in this important role and bringing experience from both the industry and BBS. I would also like to thank Soile, for her valuable contributions to the company throughout her tenure”, says Juliusz Rakowski, CEO of BBS.For more information, please contact: Juliusz Rakowski,...

BBS-Bioactive Bone Substitutes, Company announcement, 27 December 2023 at 5:00 p.m. Financial calendar and Annual General Meeting in 2024 During the year 2024, BBS-Bioactive Bone Substitutes Plc (”BBS”) will publish the financial information as follows: Financial Statements Release for the year 2023 will be published on Monday 26 February 2024 at 9.00 a.m.Half-year financial report January-June 2024 will be published on Friday 30 August 2024The Annual Report for the year 2023 will be published during the week 13/2024 the latest. The Annual General Meeting is planned to be held on Tuesday 30 April 2024. Company’s Board of Directors will convene the meeting at a later date.BBS-Bioactive Bone Substitutes Plc Juliusz Rakowski, CEOFor more information, please contact: Juliusz Rakowski, CEO+358 50 448 5132juliusz.rakowski@bbs-artebone.fiCertified...

CHATSWORTH, CA, Dec. 27, 2023 (GLOBE NEWSWIRE) — via NewMediaWire – Cavitation Technologies, Inc. (“CTi” or the “Company”) (OTCQB: CVAT), a leading ESG company designing and manufacturing innovative flow-through nano-technology systems for fluid processing applications worldwide, announces a Purchase Order of Low-Pressure Nano Tech (LPN) from B&F Greenhouse Services, Inc. (B&F), Wheatley, Ontario, Canada. Additionally, CTi and B&F have executed a collaboration agreement to explore additional applications of CTi’s water treatment nano-technologies and business development. B&F operates approximately 160 acres of farmland, mainly focused on growing bell peppers in the greenhouse, and drawing most of its water requisites from Lake Erie. B&F has been rapidly expanding its operations...

IRVINE, Calif., Dec. 27, 2023 (GLOBE NEWSWIRE) — Nymox Pharmaceutical Corporation (“Nymox”) (OTC Markets NYMXF) is pleased to provide this end-of-the year message to shareholders. The Company has overall had a good year and we expect 2024 to be an even better year for our Shareholders. 2023 saw our 2nd and 3rd applications for Nymozarfex advance to the level of being accepted for review. While the outcomes from these 2 applications cannot be guaranteed, these are very solid advances for which we are justifiably extremely proud. There has not been a fundamentally new molecular class of BPH treatment approved in decades, so it should be understandable that it takes time and is not an easy task.  The Company anticipates a busy year in 2024 that includes the many steps that daily go on in the real world of responding to all the scientific,...

This notice is published with reference to the initial public offering of the shares of AS Infortar (“Infortar”) and should be read in conjunction with Infortar’s public offering, listing and admission to trading prospectus dated 24 November 2023 (the “Prospectus”), together with Infortar’s notification on the results of the initial public offering of its shares and final price dated 11 December 2023. Infortar informs that on period commencing on 21 December 2023 and ending on 27 December 2023 (both included) the following stabilisation measures on following conditions were carried out by Swedbank AS as the Stabilising Arranger: Company: AS InfortarSecurities: INFORTAR LIHTAKTSIA, ISIN code: EE3100149394Ticker: INF1TStabilising Arranger: Swedbank ASTrading Venue: Nasdaq Tallinn Stock ExchangeStabilisation Period Start...